Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Geron Corporation    GERN

Delayed Quote. Delayed  - 09/27 03:41:36 pm
2.2237 USD   +0.62%
09/21 JOHNSON & JOHNS : JNJ) Janssen Builds On Partnership With Geron Corp..
09/12 Geron Provides Update on Imetelstat Trials Being Conducted by Jan..
09/11 GERON ANNOUNCES : 00 A.M. Eastern Time
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/21/2016 09/22/2016 09/23/2016 09/26/2016 09/27/2016 Date
2.25(c) 2.22(c) 2.2(c) 2.21(c) 2.2237 Last
3 616 814 2 708 332 1 986 006 1 500 005 49 931 Volume
+9.76% -1.33% -0.90% +0.45% +0.62% Change
More quotes
Financials ($)
Sales 2016 1,26 M
EBIT 2016 -37,6 M
Net income 2016 -37,0 M
Debt 2016 -
Yield 2016 -
Sales 2017 35,5 M
EBIT 2017 2,48 M
Net income 2017 -7,09 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017 53,64
Capi. / Sales2016 280x
Capi. / Sales2017 9,90x
Capitalization 352 M
More Financials
Company
Geron Corp. discovers and develops therapeutic products for cancer.It is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.Geron was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park,... 
More about the company
Surperformance© ratings of Geron Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on GERON CORPORATION
09/21 JOHNSON & JOHNSON (NYSE : JNJ) Janssen Builds On Partnership With Geron Corporat..
09/19 GERON CORP : Entry into a Material Definitive Agreement (form 8-K)
09/12 GERON CORP : Other Events, Financial Statements and Exhibits (form 8-K)
09/12 Geron Provides Update on Imetelstat Trials Being Conducted by Janssen
09/11 GERON ANNOUNCES CONFERENCE CALL ON S : 00 A.M. Eastern Time
08/25 GERON CORP : Other Events, Financial Statements and Exhibits (form 8-K)
08/04 GERON : reports 2Q loss
08/03 GERON CORP : Results of Operations and Financial Condition, Financial Statements..
08/03 GERON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
08/03 Geron Corporation Reports Second Quarter 2016 Financial Results and Recent Ev..
More news
Sector news : Bio Therapeutic Drugs
09/26DJPfizer Throws Out Plan to Split Into Two Companies
09/26DJSANOFI : FDA Accepts Sanofi's, Regeneron's Dermatitis Treatment for Priority Rev..
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- 2nd Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
09/19 As I Predicted, Cash-Rich Geron Optimizes Dosage In Myelofibrosis Trial
09/19 Geron inks license deal with Janssen Pharma valued up to $80M
09/15 GERON : Uncertainties Abound In Imetelstat Clinical Trial
09/14 BIOTECH FORUM DAILY DIGEST : Rocky Trading To Begin Week. Mylan In The News. Spo..
09/12 Midday Gainers / Losers
Advertisement
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Full-screen chart
Technical analysis trends GERON CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 4,38 $
Spread / Average Target 98%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John A. Scarlett President, Chief Executive Officer & Director
Hoyoung Huh Chairman
Olivia K. Bloom Chief Financial Officer, Treasurer & Executive VP
Karin Eastham Independent Director
Robert Jay Spiegel Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GERON CORPORATION-54.34%352
AMGEN, INC.6.90%129 863
GILEAD SCIENCES, INC.-20.33%106 391
CELGENE CORPORATION-11.23%82 402
REGENERON PHARMACEUTIC..-25.56%42 552
VERTEX PHARMACEUTICALS..-29.83%21 876
More Results